Application no. and date | 10798436.1 (espacenet) (Federated) (European Patent Register), 20101220 | Patent/reg. no. and date | DK/EP 2515900, 20150429 | Publication date | 20121031 | Priority no. and date | US 288739 P, 20091221 | EP pub. no. and date |
EP 2515900 20121031 | Effective date | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | Applicant ref. no. | V133027 | Inventor | ANTZELEVITCH, Charles, 101 Sylvan Way
New Hartford New York 13413, US, BELARDINELLI, Luiz, 205 Manzanita Ave.
Palo Alto California 94304, US, BURASHNIKOV, Alexander, 59 Imperial Dr.
New Hartford New York 13413, US, SHRYOCK, John, 2313 Vines Ct.
East Palo Alto California 94303, US, ZENG, Dewan, 871 Sycamore Dr.
Palo Alto California 94303, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/343 (2006.01) , A61K 31/495 (2006.01) , A61P 9/06 (2006.01) | Title | FREMGANGSMÅDE TIL BEHANDLING AF ATRIEFIBRILLATION | Int. application no. | US2010061257 | Int. publication no. | WO2011084733 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|